Exact Mass: 430.254

C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09A - Ace inhibitors, plain > C09AA - Ace inhibitors, plain D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents

Trandolapril

(2S,3aR,7aS)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]-octahydro-1H-indole-2-carboxylic acid

Trandolapril is a non-sulhydryl prodrug that belongs to the angiotensin-converting enzyme (ACE) inhibitor class of medications. It is metabolized to its biologically active diacid form, trandolaprilat, in the liver. Trandolaprilat inhibits ACE, the enzyme responsible for the conversion of angiotensin I (ATI) to angiotensin II (ATII). ATII regulates blood pressure and is a key component of the renin-angiotensin-aldosterone system (RAAS). Trandolapril may be used to treat mild to moderate hypertension, to improve survival following myocardial infarction in clinically stable patients with left ventricular dysfunction, as an adjunct treatment for congestive heart failure, and to slow the rate of progression of renal disease in hypertensive individuals with diabetes mellitus and microalbuminuria or overt nephropathy. C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09A - Ace inhibitors, plain > C09AA - Ace inhibitors, plain D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents

Indolapril

1-{2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl}-octahydro-1H-indole-2-carboxylic acid

Nivacortol

1-Ethynyl-7-(4-fluorophenyl)-10a,12a-dimethyl-1,2,3,3a,3b,4,5,7,10,10a,10b,11,12,12a-tetradecahydrocyclopenta[5,6]naphtho[1,2-f]indazol-1-ol

C28H31FN2O (430.242)

Lupulone C

6-Hydroxy-2-(2-hydroxypropan-2-yl)-5,5-bis(3-methylbut-2-en-1-yl)-7-(3-methylbutanoyl)-2,3-dihydrobenzofuran-4(5H)-one

Lupulone C is a natural product found in Humulus lupulus with data available.

SCHEMBL12713606

Lupulone D

Gordonoside A

2-O-Methylneovibsanin I

(+)-2-O-Methylneovibsanin I

C19H34N4O7 (430.2427)

Lys Arg Gln

Val Leu Trp

Trp Val Leu

arginylglutaminyllysine

Arg Lys Gln

Arg Glu Leu

Val Ala Asn Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]propanamido]-3-carbamoylpropanamido]hexanoic acid

8-[2-(3,4-dihydroxy-2,5-dimethoxyoxolan-3-yl)ethyl]-4a,7,8-trimethylspiro[2,3,5,6,7,8a-hexahydro-1H-naphthalene-4,2-oxirane]-2,3-diol

NCGC00347503-02!8-[2-(3,4-dihydroxy-2,5-dimethoxyoxolan-3-yl)ethyl]-4a,7,8-trimethylspiro[2,3,5,6,7,8a-hexahydro-1H-naphthalene-4,2-oxirane]-2,3-diol

C22H38O8_Spiro[naphthalene-1(2H),2-oxirane]-2,3-diol, octahydro-5,6,8a-trimethyl-5-[2-(tetrahydro-3,4-dihydroxy-2,5-dimethoxy-3-furanyl)ethyl]

NCGC00347503-03_C22H38O8_Spiro[naphthalene-1(2H),2-oxirane]-2,3-diol, octahydro-5,6,8a-trimethyl-5-[2-(tetrahydro-3,4-dihydroxy-2,5-dimethoxy-3-furanyl)ethyl]-

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]propanamido]-3-methylbutanamido]pentanedioic acid

C19H34N4O7 (430.2427)

Lys Leu Asn Gly

2-[(2S)-3-carbamoyl-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-methylpentanamido]propanamido]acetic acid

Leu Trp Ile

2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-carbamoylbutanamido]hexanamido]-3-methylbutanamido]acetic acid

Trp Leu Ile

Gln Arg Lys

Gln Val Gly Lys

(2S)-6-amino-2-{2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-methylbutanamido]acetamido}hexanoic acid

Gln Val Lys Gly

2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-methylbutanamido]hexanamido]acetic acid

Arg Ala Gly Lys

(2S)-6-amino-2-{2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]propanamido]acetamido}hexanoic acid

Arg Ala Lys Gly

2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]propanamido]hexanamido]acetic acid

Arg Gln Lys

Arg Gly Ala Lys

(2S)-6-amino-2-[(2S)-2-{2-[(2S)-2-amino-5-carbamimidamidopentanamido]acetamido}propanamido]hexanoic acid

Arg Gly Lys Ala

(2S)-2-[(2S)-6-amino-2-{2-[(2S)-2-amino-5-carbamimidamidopentanamido]acetamido}hexanamido]propanoic acid

Arg Lys Ala Gly

2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-5-carbamimidamidopentanamido]hexanamido]propanamido]acetic acid

Arg Lys Gly Ala

(2S)-2-{2-[(2S)-6-amino-2-[(2S)-2-amino-5-carbamimidamidopentanamido]hexanamido]acetamido}propanoic acid

Ile Trp Leu

Ile Ile Trp

Ile Leu Trp

2-[[(2Z)-4-[(1R,2R,3R,5R)-5-chloro-2-[(3R)-3-cyclohexyl-3-hydroxypropyl]-3-hydroxycyclopentyl]-2-buten-1-yl]oxy]-1-methylethyl ester, acetic acid

C23H39ClO5 (430.2486)

2-(2-Methylbutanoyl)-9-(3-methyl-2E-pentenoyl)-2b,9a-dihydroxy-4Z,10(14)-oplopadien-3-one

(1Z)-1-ethylidene-3-[(2-methylbutanoyl)oxy]-4-methylidene-2-oxo-7-(propan-2-yl)-octahydro-1H-inden-5-yl (2E)-3-methylpent-2-enoate

5-[2-(3,4-Dihydroxy-2,5-dimethoxytetrahydro-3-furanyl)ethyl]-5,6,8a-trimethyloctahydro-2H-spiro[naphthalene-1,2-oxirane]-2,3-diol

FA 26:7;O3

isopropyl 9S,11R,15S-trihydroxy-17-phenyl-18,19,20-trinor-5Z,13E-prostadienoate

C28H31FN2O (430.242)

C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid

4,8-Bis({[dimethyl(2-methyl-2-propanyl)silyl]oxy}methyl)-1,5-diazatricyclo[5.1.0.03,5]octane-2,6-diol

C20H42N2O4Si2 (430.2683)

EHop-016

C25H30N6O (430.2481)

EHop-016 is a potent and selective Rac GTPase Rac1 and Rac3 inhibitor. EHop-016 inhibits Rac1 activity with an IC50 of 1.1 μM in MDA-MB-435 cells. EHop-016 inhibits Vav2 interaction with Rac, Rac-activated PAK1, lamellipodia formation, and cell migration[1][2].

Benderizine

C28H34N2O2 (430.262)

1,4-bis(chloromethyl)-2,5-dioctoxybenzene

C24H40Cl2O2 (430.2405)

TETRABUTYLPHOSPHONIUM TOLUENE-4-SULFONATE

C23H43O3PS (430.267)

2,6-Dibenzhydryl-2,6-diazaspiro[3.3]heptane

C31H30N2 (430.2409)

4,4,5,5-tetramethyl-2-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)anthracen-2-yl]-1,3,2-dioxaborolane

C26H32B2O4 (430.2487)

1-[2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid

Sodium Cholate

SODIUM CHOLATE

C24H39NaO5 (430.2695)

Digestion and Absorption of Fats: Bile acids are crucial for the digestion and absorption of dietary fats and fat-soluble vitamins (A, D, E, and K) in the small intestine. They achieve this by emulsifying large fat droplets into smaller droplets, increasing the surface area for action by lipase, an enzyme that breaks down fats. Cholesterol Metabolism: Bile acids are synthesized from cholesterol in the liver. They play a key role in cholesterol homeostasis by facilitating the excretion of cholesterol from the body. This process is important for regulating blood cholesterol levels. Bile Formation: Bile acids are a major component of bile, which is produced by the liver and stored in the gallbladder. Bile is released into the small intestine to aid in the digestion and absorption of fats. Hormone-like Functions: Bile acids can act as signaling molecules, influencing various metabolic processes through activation of nuclear receptors such as the farnesoid X receptor (FXR) and the G protein-coupled bile acid receptor 1 (GPBAR1, also known as TGR5). Lipid Solubility: Bile acids are amphipathic molecules, meaning they have both hydrophobic and hydrophilic regions. This property allows them to solubilize lipids and lipid-soluble substances, aiding in their transport and absorption. Microbial Metabolism: In the intestine, bile acids can influence the composition of the gut microbiota by affecting the growth of different bacterial species. The gut microbiota, in turn, can modify bile acids, influencing their function and the overall metabolic state of the host. D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids

Diphenylacetylene-4,4-diboronic acid bis(pinacol) ester

C26H32B2O4 (430.2487)

3,4-Dihydro-7-(4-(4-(1-naphthyl)piperazino)butoxy)-1,8-naphthyridine-2(1H)-one

C26H30N4O2 (430.2369)

Resocortol butyrate

C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid

Trandolapril-d5

Carbifene

C28H34N2O2 (430.262)

C19H34N4O7 (430.2427)

A tetrapeptide composed of L-alanine, two L-leucine units, and L-aspartic acid joined in sequence by peptide linkages.

asnovolin J

Asp-Val-Val-Val

A 17-oxo steroid that is andrastin D in which the keto group at position 3 has undergone formal reduction to give the corresponding 3alpha-hydroxy compound.

Andrastin F

A 17-oxo steroid that is andrastin D in which the keto group at position 3 has undergone formal reduction to give the corresponding 3beta-hydroxy compound.

methyl (3R)-3-[(2E,6E)-9-[(2R)-3,3-dimethyloxiran-2-yl]-3,7-dimethylnona-2,6-dienyl]-6-hydroxy-2,3,5-trimethyl-4-oxocyclohexa-1,5-diene-1-carboxylate

Bimatoprost isopropyl ester

17-phenyl-trinor-PGF2alpha isopropyl ester

Leu-Trp-Leu

ST 22:0;O3;S

C22H38O6S (430.2389)

ST 26:4;O5

ST 22:0;O8

Cholic acid (sodium)

C24H39NaO5 (430.2695)

Cholic acid sodium is a major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion. Cholic acid sodium is orally active[1][2]. Cholic acid sodium is a major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion. Cholic acid sodium is orally active[1][2].

(1e,3s,3ar,5r,7s,7as)-1-ethylidene-7-isopropyl-3-[(2-methylbutanoyl)oxy]-4-methylidene-2-oxo-hexahydroinden-5-yl (2e)-3-methylpent-2-enoate

(8ar)-5-methyl-3-(pentadecyloxy)-1h,8h,8ah-3λ⁵-furo[3,4-e][1,3,2]dioxaphosphepine-3,6-dione

(3r,8as)-5-propyl-3-(tridecyloxy)-1h,8h,8ah-3λ⁵-furo[3,4-e][1,3,2]dioxaphosphepine-3,6-dione

15-o-methyl-14-epi-neovibsanin f

{"Ingredient_id": "HBIN001710","Ingredient_name": "15-o-methyl-14-epi-neovibsanin f","Alias": "NA","Ingredient_formula": "C26H38O5","Ingredient_Smile": "CC(=CC(=O)OC=CC1C2=C(COC2CC(=O)C)C3CC1(CCC3C(C)(C)OC)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14392","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

15-o-methylneovibsanin f

{"Ingredient_id": "HBIN001713","Ingredient_name": "15-o-methylneovibsanin f","Alias": "NA","Ingredient_formula": "C26H38O5","Ingredient_Smile": "CC(=CC(=O)OC=CC1C2=C(COC2CC(=O)C)C3CC1(CCC3C(C)(C)OC)C)C","Ingredient_weight": "430.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14607","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "11154655","DrugBank_id": "NA"}

2-o-methylneovibsanin h

{"Ingredient_id": "HBIN006255","Ingredient_name": "2-o-methylneovibsanin h","Alias": "NA","Ingredient_formula": "C26H38O5","Ingredient_Smile": "CC(=CCCC1(CC(C2=C(C1C=COC(=O)C=C(C)C)C(OC2)CC(=O)C)OC)C)C","Ingredient_weight": "430.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14608","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "11750791","DrugBank_id": "NA"}

2-o-methylneovibsanin i

(2r,3s)-3-hydroxy-3-[(2s,3s,4s,5r,6s)-3-hydroxy-5-{[(2e,4s)-4-hydroxydec-2-enoyl]oxy}-2,4,6-trimethyloxan-2-yl]-2-methylpropanoic acid